Olema Pharmaceuticals, Inc. (OLMA) has 20 known insider and institutional holders on record. The largest holder is Bain Capital Life Sciences Investors, LLC with 7,500,000 shares. Other notable holders include LAMPERT MARK N and Paradigm Biocapital Advisors LP.
Over the last 12 months, insiders have made 40 transactions in OLMA stock — 15 buys (valued at $14.93M) and 13 sells (valued at $10.04M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
OLMA Insider Ownership
Top Holder
Bain Capital Life Sciences Investors, LLC
7,500,000 shares
Buys (12 mo)
15
$14.93M value
Sells (12 mo)
13
$10.04M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
7,500,000 |
2025-01-13 |
|
| 2 |
Lampert Mark N |
Director |
2,906,659 |
2022-06-14 |
|
| 3 |
Paradigm Biocapital Advisors Lp |
10 Percent Owner |
783,118 |
2024-08-05 |
|
| 4 |
Harmon Cyrus |
Director |
727,770 |
2026-01-21 |
|
| 5 |
Bohen Sean |
President and CEO |
275,000 |
2026-02-04 |
|
| 6 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
239,727 |
2026-01-15 |
|
| 7 |
Moriarty John B |
EVP, Ch. Legal Officer & Sec. |
150,000 |
2023-02-02 |
|
| 8 |
Horn Kinney |
Chief Business Officer |
150,000 |
2023-02-02 |
|
| 9 |
Zojwalla Naseem |
Chief Medical Officer |
106,250 |
2026-02-04 |
|
| 10 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
106,250 |
2026-02-04 |
|
| 11 |
Kushner Peter J. |
Officer |
61,750 |
2022-02-03 |
|
| 12 |
Mccormick Frank |
Director |
56,964 |
2020-11-19 |
|
| 13 |
Mitchell Shawnte |
Chief Legal Officer |
56,250 |
2026-02-04 |
|
| 14 |
Clark Ian T |
Director |
24,150 |
2025-06-13 |
|
| 15 |
Rappaport Andrew |
Director |
24,150 |
2025-06-13 |
|
| 16 |
Horning Sandra |
Director |
24,150 |
2025-06-13 |
|
| 17 |
Graham G. Walmsley |
Director |
24,150 |
2025-06-13 |
|
| 18 |
Larson Yi |
Director |
24,150 |
2025-06-13 |
|
| 19 |
Bvf Partners L P/il |
Other: See Explanation of Responses |
24,150 |
2025-06-13 |
|
| 20 |
Garland J. Scott |
Director |
24,150 |
2025-06-13 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-04 |
Mitchell Shawnte |
Chief Legal Officer |
Informative Sell |
233 |
$24.69 |
$5.75K |
| 2026-03-03 |
Mitchell Shawnte |
Chief Legal Officer |
Informative Sell |
15,000 |
$23.01 |
$345.15K |
| 2026-02-02 |
Austin Sasha Lu |
VP of Finance and Controller |
RSU Award |
11,700 |
- |
- |
| 2026-02-01 |
Austin Sasha Lu |
VP of Finance and Controller |
Unknown |
13,000 |
$2.44 |
$31.72K |
| 2026-01-30 |
Austin Sasha Lu |
VP of Finance and Controller |
Unknown |
45,000 |
$4.37 |
$196.65K |
| 2026-02-02 |
Zojwalla Naseem |
Chief Medical Officer |
RSU Award |
106,250 |
$25.65 |
$2.73M |
| 2026-02-02 |
Bohen Sean |
President and CEO |
RSU Award |
275,000 |
$25.65 |
$7.05M |
| 2026-02-02 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
RSU Award |
106,250 |
$25.65 |
$2.73M |
| 2026-02-02 |
Mitchell Shawnte |
Chief Legal Officer |
RSU Award |
56,250 |
$25.65 |
$1.44M |
| 2026-01-20 |
Harmon Cyrus |
Director |
Informative Sell |
10,000 |
$26.88 |
$268.8K |
| 2026-01-14 |
Harmon Cyrus |
Director |
Informative Sell |
3,489 |
$29.12 |
$101.6K |
| 2026-01-15 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informative Sell |
100,000 |
$28.73 |
$2.87M |
| 2026-01-13 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informative Sell |
3,822 |
$28.01 |
$107.05K |
| 2026-01-14 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Option Exercise (Sell) |
50,000 |
$4.87 |
$243.5K |
| 2026-01-13 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Option Exercise (Sell) |
50,000 |
$4.87 |
$243.5K |
| 2026-01-12 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Informative Sell |
10,000 |
$28.34 |
$283.4K |
| 2025-12-26 |
Bohen Sean |
President and CEO |
Gift (Given) |
8,500 |
- |
- |
| 2025-12-22 |
Harmon Cyrus |
Director |
Informative Sell |
2,881 |
$28.53 |
$82.19K |
| 2025-12-23 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
99,509 |
$27.66 |
$2.75M |
| 2025-12-22 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
100,000 |
$28.04 |
$2.8M |
| 2025-12-19 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
12,921 |
$28.93 |
$373.8K |
| 2025-12-19 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Gift (Given) |
9,000 |
- |
- |
| 2025-12-19 |
Clark Ian T |
Director |
Option Exercise (Sell) |
21,520 |
$3.61 |
$77.69K |
| 2025-12-08 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Gift (Given) |
75,000 |
- |
- |
| 2025-11-26 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Gift (Given) |
225,000 |
- |
- |
